JUL 22, 2020 12:00 AM PDT

Immunotherapy: the risk for cancer patients with COVID-19

Research presented at the American Association for Cancer Research Virtual Meeting: COVID-19 and Cancer earlier this week reports that preliminary data suggest that immunotherapy doesn't necessarily worsen complications for patients with both COVID-19 and cancer. The research was presented by Layne Weatherford, Ph.D. 

."Many COVID-19 complications result from an overactive immune response, leading to an increased production of proteins called cytokines," Weatherford says. "Increased production of these proteins can cause issues like respiratory failure. Patients with cancer are more susceptible to COVID-19 infection as well as severe complications from it.

"Many patients with cancer are treated with immunotherapy, which activates the immune system against cancer to destroy it. In patients with both COVID-19 and cancer, our team thought that immunotherapy might increase the immune system response, which could already be overactive because of the COVID-19 infection."

This, in turn, could adversely affect patients’ health. Or at least that has been the concern that medical providers have had for their patients. Yet, while too early to tell for certain, the data looks like it may be telling another story. 

"We are continuing to investigate whether immunotherapy causes an increased production of these proteins by immune cells from COVID-19 patients, but our initial findings are showing that immunotherapy is not significantly impacting it," she adds.

Photo: Pixabay

Weatherford is a postdoctoral fellow in the lab of Trisha Wise-Draper, Ph.D., at the University of Cincinnati Cancer Center. It is there that Weatherford and colleagues are examining blood samples from patients with cancer taken from the UC COVID-19 biorepository to see how immune checkpoint inhibitors are impacting COVID-19 immune cells. 

So far, the team has discovered that metformin, a common diabetes drug, has been effective in lowering the production of these proteins by immune cells of COVID-19 patients. "These are promising, initial findings," Wise-Draper comments. "Additional research is needed, but our results show that we might be able to treat COVID-19 complications with metformin or a similar drug one day."

Sources: Eureka Alert

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
JUL 15, 2020
Cancer
Mortality rate disparities in hospitals with different star ratings
JUL 15, 2020
Mortality rate disparities in hospitals with different star ratings
The Center for Medicare and Medicaid Services' "Star Rating" system compares the quality of care of hospit ...
AUG 05, 2020
Cancer
A New Test to Analyze Cell-Free DNA in Cancer Diagnostics
AUG 05, 2020
A New Test to Analyze Cell-Free DNA in Cancer Diagnostics
Cell-free DNA (cfDNA) are small pieces of genomic DNA that have escaped into the bloodstream either through active relea ...
AUG 06, 2020
Clinical & Molecular DX
Gut Feeling: Spotting the Early Signs of Gastric Cancer
AUG 06, 2020
Gut Feeling: Spotting the Early Signs of Gastric Cancer
In a study published in Science Advances, scientists propose a new method for diagnosing gastric cancer, the third leadi ...
AUG 12, 2020
Cancer
Comparing Nivolumab and Pembrolizumab in the Treatment of Lung Cancer
AUG 12, 2020
Comparing Nivolumab and Pembrolizumab in the Treatment of Lung Cancer
Since the 1940s, chemotherapy has been a primary treatment option for cancer. The late 20th century brought a new type o ...
AUG 14, 2020
Cancer
Controlling Tumor Blood Flow to Increase Therapy Effectiveness
AUG 14, 2020
Controlling Tumor Blood Flow to Increase Therapy Effectiveness
Nowadays, most cancer drugs target a protein or inhibit a critical cellular process. Modern therapies have varying level ...
SEP 02, 2020
Cancer
Does Adjuvant Chemotherapy Really Help in a Rare Signet-ring Cell Carcinoma
SEP 02, 2020
Does Adjuvant Chemotherapy Really Help in a Rare Signet-ring Cell Carcinoma
For many rare diseases, there is a lack of a “standard” treatment options. This is more prevalent in diverse ...
Loading Comments...